A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteries

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Cui, Song ^a   Liu, Jing Hua ^a   Song, Xian Tao ^a   Ma, Guo Lin ^b   Du, Ben Jun ^c   Lv, Shu Zheng ^a   Meng, Li Jun ^d   Gao, Quan Sheng ^e   Li, Kefeng ^f  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c FIRST MILITARY MEDICAL UNIVERSITY   (China)

^d Binzhou Central Hospital   (China)

^e BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN; RAPAMYCIN; ANTIBODY; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTICLE; BARE METAL STENT; CARDIOVASCULAR STENT; CORONARY ARTERY; DRUG ELUTING STENT; ENDOGLIN ANTIBODY COATED STENT; INFLAMMATION; MORPHOMETRICS; NEOINTIMA; NONHUMAN; SCANNING ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; CORONARY BLOOD VESSEL; DISEASE MODEL; HUMAN; IMMUNOLOGY; PATHOLOGY; SWINE;

ANIMALS; ANTIBODIES; ANTIGENS, CD; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG-ELUTING STENTS; HUMANS; INFLAMMATION; NEOINTIMA; RECEPTORS, CELL SURFACE; SWINE;

EID: 84901796857     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/428619     Document Type: Article

References (37)

1. Lüscher T. F., Steffel J., Eberli F. R., Joner M., Nakazawa G., Tanner F. C., Virmani R., Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007 115 8 1051 1058 2-s2.0-33847259689 10.1161/CIRCULATIONAHA.106.675934 (Pubitemid 46328299)
2. Slavin L., Chhabra A., Tobis J. M., Drug-eluting stents: preventing restenosis. Cardiology in Review 2007 15 1 1 12 2-s2.0-33845751988 10.1097/01.crd.0000200844.16899.fc (Pubitemid 46005943)
3. Kraitzer A., Kloog Y., Zilberman M., Approaches for prevention of restenosis. Journal of Biomedical Materials Research B-Applied Biomaterials 2008 85 2 583 603 2-s2.0-42649103004 10.1002/jbm.b.30974 (Pubitemid 351600466)
4. Kipshidze N., Dangas G., Tsapenko M., Moses J., Leon M. B., Kutryk M., Serruys P., Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. Journal of the American College of Cardiology 2004 44 4 733 739 2-s2.0-4143131081 10.1016/j.jacc.2004.04.048 (Pubitemid 39099565)
5. Werner N., Junk S., Laufs U., Link A., Walenta K., Bohm M., Nickenig G., Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circulation Research 2003 93 2 e17 24 2-s2.0-0041733082
6. Walter D. H., Rittig K., Bahlmann F. H., Kirchmair R., Silver M., Murayama T., Nishimura H., Losordo D. W., Asahara T., Isner J. M., Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002 105 25 3017 3024 2-s2.0-0037173080 10.1161/01.CIR.0000018166. 84319.55 (Pubitemid 34693836)
7. Serruys P. W., Kutryk M. J. B., Ong A. T. L., Coronary-artery stents. The New England Journal of Medicine 2006 354 5 483 495 2-s2.0-32044431845 10.1056/NEJMra051091 (Pubitemid 43200299)
8. Nakazawa G., Finn A. V., Joner M., Ladich E., Kutys R., Mont E. K., Gold H. K., Burke A. P., Kolodgie F. D., Virmani R., Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008 118 11 1138 1145 2-s2.0-54049125008 10.1161/CIRCULATIONAHA.107. 762047
9. Finn A. V., Nakazawa G., Joner M., Kolodgie F. D., Mont E. K., Gold H. K., Virmani R., Vascular responses to drug eluting stents: importance of delayed healing. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 7 1500 1510 2-s2.0-34250835092 10.1161/ATVBAHA.107.144220 (Pubitemid 46986103)
10. Shirota T., Yasui H., Shimokawa H., Matsuda T., Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 2003 24 13 2295 2302 2-s2.0-12444320975 10.1016/S0142-9612(03)00042-5 (Pubitemid 36434048)
11. Nakazawa G., Granada J. F., Alviar C. L., Tellez A., Kaluza G. L., Guilhermier M. Y., Parker S., Rowland S. M., Kolodgie F. D., Leon M. B., Virmani R., Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization. JACC: Cardiovascular Interventions 2010 3 1 68 75 2-s2.0-74049141407 10.1016/j.jcin.2009.09.015
12. Aoki J., Serruys P. W., van Beusekom H., Ong A. T. L., McFadden E. P., Sianos G., van der Giessen W. J., Regar E., De Feyter P. J., Davis H. R., Rowland S., Kutryk M. J. B., Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First in Man) registry. Journal of the American College of Cardiology 2005 45 10 1574 1579 2-s2.0-21044445480 10.1016/j.jacc.2005.01.048 (Pubitemid 40704488)
13. Bellon T., Corbi A., Lastres P., Cales C., Cebrian M., Vera S., Cheifetz S., Massague J., Letarte M., Bernabeu C., Identification and expression of two forms of the human transforming growth factor- β -binding protein endoglin with distinct cytoplasmic regions. European Journal of Immunology 1993 23 9 2340 2345 2-s2.0-0027259431 (Pubitemid 23265903)
14. Yamashita H., Ichijo H., Grimsby S., Morén A., Ten Dijke P., Miyazono K., Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor- β Journal of Biological Chemistry 1994 269 3 1995 2001 2-s2.0-0028057726 (Pubitemid 24035405)
15. Cheifetz S., Bellon T., Cales C., Vera S., Bernabeu C., Massague J., Letarte M., Endoglin is a component of the transforming growth factor- β receptor system in human endothelial cells. Journal of Biological Chemistry 1992 267 27 19027 19030 2-s2.0-0026646785
16. St.-Jacques S., Cymerman U., Pece N., Letarte M., Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor- β binding protein of endothelial and stromal cells. Endocrinology 1994 134 6 2645 2657 2-s2.0-0028231917 10.1210/en.134.6. 2645 (Pubitemid 24170882)
17. Gougos A., St.-Jacques S., Greaves A., O'Connell P. J., d'Apice A. J. F., Buhring H.-J., Bernabeu C., Van Mourik J. A., Letarte M., Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. International Immunology 1992 4 1 83 92 2-s2.0-0026585507
18. Qu R., Silver M. M., Letarte M., Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation. Cell and Tissue Research 1998 292 2 333 343 2-s2.0-0031981468 10.1007/s004410051064 (Pubitemid 28230220)
19. Fonsatti E., Nicolay H. J. M., Altomonte M., Covre A., Maio M., Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours. Cardiovascular Research 2010 86 1 12 19 2-s2.0-77949370983 10.1093/cvr/cvp332
20. Li H. H., Kedar V., Zhang C., McDonough H., Arya R., Wang D.-Z., Patterson C., Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. Journal of Clinical Investigation 2004 114 8 1058 1071 2-s2.0-9644270401 10.1172/JCI200422220 (Pubitemid 39578695)
21. Ma X., Hibbert B., Dhaliwal B., Seibert T., Chen Y.-X., Zhao X., O'Brien E. R., Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3 inhibitor. Cardiovascular Research 2010 86 2 338 345 2-s2.0-77951668408 10.1093/cvr/cvq047
22. Steigerwald K., Merl S., Kastrati A., Wieczorek A., Vorpahl M., Mannhold R., Vogeser M., Hausleiter J., Joner M., Schömig A., Wessely R., The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts. Biomaterials 2009 30 4 632 637 2-s2.0-56549128062 10.1016/j.biomaterials.2008.10.005
23. Schwartz R. S., Huber K. C., Murphy J. G., Edwards W. D., Camrud A. R., Vlietstra R. E., Holmes D. R., Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. Journal of the American College of Cardiology 1992 19 2 267 274 2-s2.0-0026515530
24. Young J. H., Myung H. J., Sang R. L., Seo N. H., Kye H. K., Hyung W. P., Ju H. K., Kim W., Ahn Y., Jeong G. C., Jong C. P., Jung C. K., Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model. Journal of Korean Medical Science 2007 22 5 802 809 2-s2.0-36148944294
25. Blindt R., Vogt F., Astafieva I., Fach C., Hristov M., Krott N., Seitz B., Kapurniotu A., Kwok C., Dewor M., Bosserhoff A.-K., Bernhagen J., Hanrath P., Hoffmann R., Weber C., A novel drug-eluting stent coated with an integrin-binding cyclic arg-gly-asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. Journal of the American College of Cardiology 2006 47 9 1786 1795 2-s2.0-33646201485 10.1016/j.jacc.2005.11.081
26. Soehnlein O., Wantha S., Simsekyilmaz S., Döring Y., Megens R. T. A., Mause S. F., Drechsler M., Smeets R., Weinandy S., Schreiber F., Gries T., Jockenhoevel S., Möller M., Vijayan S., van Zandvoort M. A. M. J., Agerberth B., Pham C. T., Gallo R. L., Hackeng T. M., Liehn E. A., Zernecke A., Klee D., Weber C., Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Science Translational Medicine 2011 3 103 103ra98 2-s2.0-84859883295
27. Pfisterer M. E., Late stent thrombosis after drug-eluting stent implantation for acute myocardial infarction a new red flag is raised. Circulation 2008 118 11 1117 1119 2-s2.0-54049126919 10.1161/CIRCULATIONAHA.108. 803627
28. Ertaş G., van Beusekom H. M., van der Giessen W. J., Late stent thrombosis, endothelialisation and drug-eluting stents. The Netherlands Heart Journal 2009 17 4 177 180 2-s2.0-70349267581 10.1007/BF03086242
29. Houtgraaf J. H., Duckers H. J., Endothelial progenitor cell (EPC) capture to aid vascular repair following coronary stenting: a new frontier in stent technology? EuroIntervention C 2008 4 67 71 2-s2.0-63149104800
30. Chong E., Poh K. K., Liang S., Lee R. C.-H., Low A., Teo S.-G., Tan H. C., Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction. Journal of Interventional Cardiology 2010 23 2 101 108 2-s2.0-77950557109 10.1111/j.1540-8183.2010.00534.x
31. Dallas N. A., Samuel S., Xia L., Fan F., Gray M. J., Lim S. J., Ellis L. M., Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clinical Cancer Research 2008 14 7 1931 1937 2-s2.0-42249110348 10.1158/1078-0432.CCR-07-4478 (Pubitemid 351551101)
32. Lastres P., Letamendía A., Zhang H., Rius C., Almendro N., Raab U., López L. A., Langa C., Fabra A., Letarte M., Bernabéu C., Endoglin modulates cellular responses to TGF- β 1. Journal of Cell Biology 1996 133 5 1109 1121 2-s2.0-15844419905 10.1083/jcb.133.5.1109 (Pubitemid 26172515)
33. Lebrin F., Deckers M., Bertolino P., Ten Dijke P., TGF- β receptor function in the endothelium. Cardiovascular Research 2005 65 3 599 608 2-s2.0-12344273467 10.1016/j.cardiores.2004.10.036 (Pubitemid 40138980)
34. Liehn E. A., Schober A., Weber C., Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in apoE-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 10 1891 1896 2-s2.0-5344252333 10.1161/01.ATV. 0000143135.71440.75 (Pubitemid 39350309)
35. Banerjee S., Brilakis E., Zhang S., Roesle M., Lindsey J., Philips B., Blewett C. G., Terada L. S., Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 2006 189 1 70 75 2-s2.0-33748976490 10.1016/j.atherosclerosis.2006.04.026 (Pubitemid 44441298)
36. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., Sasaki K.-I., Shimada T., Oike Y., Imaizumi T., Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001 103 23 2776 2779 2-s2.0-0035849588 (Pubitemid 32550062)
37. Werner N., Priller J., Laufs U., Endres M., Böhm M., Dirnagl U., Nickenig G., Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibition. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 10 1567 1572 2-s2.0-0036790415 10.1161/01.ATV. 0000036417.43987.D8